Aniwan Satimai, Harmsen W Scott, Tremaine William J, Kane Sunanda V, Loftus Edward V
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN; Division of Gastroenterology, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
Mayo Clin Proc. 2018 Oct;93(10):1415-1422. doi: 10.1016/j.mayocp.2018.03.004. Epub 2018 Jul 4.
To determine the mortality of Crohn disease (CD) and ulcerative colitis (UC) and temporal trends in mortality.
All 895 residents of Olmsted County, Minnesota, first diagnosed as having inflammatory bowel disease (IBD) (411 with CD and 484 with UC) from January 1, 1970, through December 31, 2010, were followed through June 30, 2016. Standardized mortality ratios (SMRs) were computed-expected rates were derived from the US 2010 background population. To determine overall and cause-specific mortality, each patient with IBD was matched with 5 county residents, and Cox regression analysis was used to assess time to death.
A total of 895 patients with IBD and 4475 patients without IBD were included. Seventy-four patients with CD died compared with 59.2 expected (SMR, 1.25; 95% CI, 0.98-1.57), and 77 patients with UC died compared with 108.1 expected (SMR, 0.71; 95% CI, 0.56-0.89). In CD, the risk of dying was significantly associated with diagnosis from 1970 through 1979 (SMR, 1.90; 95% CI, 1.24-2.78). Of those diagnosed after 1980, the risk of dying in patients with CD was similar to the US background population. In UC, the risk of dying was less than expected in all periods of diagnosis. In the Cox regression analysis, overall mortality was not significantly higher in CD (hazard ratio [HR], 1.26; 95% CI, 0.97-1.63) or UC (HR, 0.89; 95% CI, 0.70-1.14) compared with the comparison cohort. The risk of dying of digestive diseases (HR, 3.70; 95% CI, 1.24-11.0) and respiratory diseases (HR, 2.72; 95% CI, 1.36-5.44) was increased in CD but not UC.
In this cohort, overall mortality in patients with CD diagnosed after 1980 did not differ from that in the US background population. Overall mortality in patients with UC diagnosed from 1970 through 2010 was lower than the expected mortality.
确定克罗恩病(CD)和溃疡性结肠炎(UC)的死亡率以及死亡率的时间趋势。
对明尼苏达州奥尔姆斯特德县1970年1月1日至2010年12月31日首次诊断为炎症性肠病(IBD)(411例CD和484例UC)的所有895名居民进行随访,直至2016年6月30日。计算标准化死亡率(SMR)——预期死亡率来自美国2010年的背景人群。为确定总体死亡率和特定病因死亡率,将每位IBD患者与5名县居民进行匹配,并使用Cox回归分析评估死亡时间。
共纳入895例IBD患者和4475例非IBD患者。CD患者中有74例死亡,而预期死亡数为59.2例(SMR,1.25;95%CI,0.98 - 1.57),UC患者中有77例死亡,而预期死亡数为108.1例(SMR,0.71;95%CI,0.56 - 0.89)。在CD中,1970年至1979年诊断的患者死亡风险显著升高(SMR,1.90;95%CI,1.24 - 2.78)。1980年后诊断的CD患者死亡风险与美国背景人群相似。在UC中,各诊断时期的死亡风险均低于预期。在Cox回归分析中,与对照队列相比,CD(风险比[HR],1.26;95%CI,0.97 - 1.63)或UC(HR,0.89;95%CI,0.70 - 1.14)的总体死亡率均无显著升高。CD患者死于消化系统疾病(HR,3.70;95%CI,1.24 - 11.0)和呼吸系统疾病(HR,2.72;95%CI,1.36 - 5.44)的风险升高,而UC患者未出现这种情况。
在该队列中,1980年后诊断的CD患者总体死亡率与美国背景人群无异。1970年至2010年诊断的UC患者总体死亡率低于预期死亡率。